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ABSTRACT 
Previous studies have shown that apoE is upregulated in injured nerves, and that it may participate in 
nerve regeneration by recycling lipids from the degenerating myelin sheath to axonal growth cones. 
However, these studies fail to differentiate apoE function in degeneration and regeneration, because of 
temporal juxtaposition of degeneration and regeneration in these models. In this study, we characterized the 
apoE expression during olfactory nerve regeneration in mice, which occurs over an extended seven week 
period. Olfactory nerves were lesioned in 2-3-month-old mice by intransal irrigation of Triton X-100. 
Following lesioning the olfactory bulbs were collected at 0, 3, 7, 21, 42, and 56 days post-injury, and apoE 
levels in the bulbs were determined by immunoblot analysis. ApoE level peaked at 3 days-post lesion, 
reaching a concentration twice which is found in the normal olfactory bulb. The apoE level stayed elevated 
by approximately 1.5 times the normal level at 7 through 21 days after injury, and thereafter gradually 
returned to normal by 56 days. These data suggest that apoE functions in the central nervous system to 
promote efficient repair of neural structures following injury. 
An extension of this observation is the hypothesis that if apoE is important in nerve repair, then nerve 
regrowth should be either incomplete or delayed in the absence of apoE. I tested this postulate by comparing 
olfactory nerve repair in apoE gene deficient/apoE gene knockout (apoE KO) with control mice. Olfactory 
nerve recovery was assessed by immunoblotting of GAP 43, a marker for juvenile olfactory neurons. 
Immunoblot analysis revealed that GAP 43 levels in control animals increased by approximately two times the 
normal level at 3 days post-lesion, and returned back to baseline at 7 days after injury. At 21 days post-lesion the 
GAP 43 level increased dramatically reaching a concentration 3 times which is found in the normal olfactory 
bulb. The GAP 43 level stayed elevated until 42 days, and thereafter gradually returned to normal by 56 days. 
Even though the GAP 43 time course in apoE KO mice followed a pattern similar to that observed in control 
animals, the major increase in GAP 43 was observed on 42 days post lesion. This is a two weeks delay from 
that observed in control animals, suggesting that the generation of new olfactory neurons is delayed by two 
weeks in apoE KO mice. 
To confirm the GAP 43 data and examine the effects of apoE deficiency in the maturation of olfactory 
neurons, I examined the expression of the olfactory marker protein (OMP), a marker for adult olfactory 
neurons. Immunoblot analysis revealed that OMP levels in the bulb of control animals gradually declined 
following nerve lesioning, decreasing to approximately 50% of the normal level at 7 days post lesion. Thereafter 
OMP levels sharply increased to about 80% of the normal level at 21 days post lesion, and then gradually 
increased to normal by 56 days. In apoE KO animals the OMP time course was different than that of control 
animals. First, OMP levels continued to decrease in apoE KO animals until 21 days post-lesion decreasing to 
approximately 40% of normal OMP levels. Thereafter OMP levels increased slowly, reaching only 50% of 
normal level on 42 days post-lesion. The OMP levels gradually returned to normal after 56 days following 
injury in apoE KO animals, similar to that observed in control mice. Taken together the OMP data 
demonstrate that maturation of olfactory neurons is delayed by about two weeks in apoE KO mice as 
compared to control animals, and that it is consistent with the results from our GAP 43 studies. 
The results from this study demonstrate that apoE has a tremendous impact on neurite outgrowth, and 
consequently has a significant effect on neuronal plasticity. The ~oE is upregulated during periods 
predominated by degeneration of the olfactory nerve and at the early stages of regeneration. We hypothesize 
that apoE is upregulated to facilitate efficient repair of neural structures following injury. The association of 
apoE phenotype with dementing illnesses, like Alzheimer's disease, may represent a diminished ability to 
support a lifetime of nerve regeneration. 
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INTRODUCTION: 
Apolipoprotein-E (apoE) is a 34-kDa protein component of lipoproteins that functions in the 
redistribution of cholesterol and other lipids by interacting with lipoprotein receptors on target cells 
(1-4). Receptor-lipoprotein binding initiates cellular uptake and degradation of the lipoproteins. The 
lipid is then available for use in the regulation of intracellular cholesterol metabolism. The gene for 
apoE is located on the long arm of chromosome 19 and is highly polymorphic. The primary structures 
of apoE from 10 different species have been determined (5). ApoE ranges in length from 279 to 310 
residues, with a high degree of sequence conservation among species. There are three major isoforms 
of apoE that exist in humans-: apoE2, apoE3 and apoE4- that differ in amino acids at positions 112 
and 158 (5-8). The most common isoform, apoE3, is secreted as a 299 amino acid protein with a 
cysteine at position 112 and arginine at position 158. Both positions contain cysteine in apoE2 and 
arginine in apoE4. Mice have one form of apoE which resembles apoE4 by having arginine at both 
positions 112 and 158 (5). 
ApoE In The Nervous System: 
Apolipoprotein-E is the major apolipoprotein in the brain and cerebrospinal fluid (CSF) (9-11). 
It is principally synthesized and secreted by glial cells, particularly astrocytes and microglia (9, 12, 
13). The apoE containing lipoproteins in CSF have cholesterol, cholesteryl esters, phosphatidyl-
choline and small amounts of sphingomyelin and phosphotidylethanolamine. It has been shown that 
apoE is the only lipoprotein in the CSF that can interact with lipoprotein receptors (10, 11). 
Cells within the brain have been known to express four receptors for apoE-containing 
lipoproteins: a) the low density lipoprotein (LDL) receptor, b) the LDL receptor-related protein 
{LRP), c) the very low density lipoprotein (VLDL) receptor, and d) the glycoprotein (gp) 330. The 
LDL receptor and the LRP are expressed by neurons (10, 12). It has been reported that the VLDL 
receptor in the CNS is expressed in some human neurons, whereas gp330 is expressed by brain 
ependymal cells ( 4, 15-17). It has been demonstrated that human apoE-containing lipoproteins bind 
to fibroblast LDL receptors and that the LDL receptor and LRP mediate the binding and 
internalization of apoE containing lipoproteins in cultured neurons ( 18). These studies suggest that 
apoE and apoE- containing lipoproteins are present within the brain where they can interact with 
neurons and that lipoprotein transport by apoE is important for normal functioning of adult neurons. 
3 
ApoE And Peripheral Nerve Regeneration: 
Peripheral nerve maintenance and repair have been suggested as possible roles of apoE in the 
PNS ( 1, 19- 22). In rats, the synthesis of apoE increases by 250- to 350- fold within 3 weeks post-
injury of peripheral nerve (23, 24). It has also been reported that following peripheral lesioning, 
macrophages synthesize and release apoE which accumulates to 5% of total extracellular protein 
(25) and has been proposed to scavange cholestrol from the degenerating myelin, and recycle it to the 
growth cones of sprouting axons by LDL-receptor -mediated endocytosis for membrane biosynthesis 
(1, 26, 27). During regeneration of the peripheral nerve, the increased expression of apoE is 
negatively regulated by translational or post-translational control, but not by transcriptional control 
(28). It has been proposed that apoE might be involved in neurodegenerative processes by isoform 
specific effects on neurite extension and cytoskeletal stability (29, 30). In vitro studies have shown 
that addition of apoE3 to dorsal root ganglion neurons in culture stimulates neurite extension 
whereas apoE4 decreased outgrowth (31). These data suggest that apoE is important for peripheral 
nerve regeneration (1); however, its precise role in the CNS remains unknown. 
ApoE And CNS Plasticity: 
The functional importance of apoE in the CNS is even less clear. ApoE immunoreactivity has 
been reported in neurons of human AD brains (32, 33, 34) and in the rat brain after ischemia (35). It 
has been shown that expression of apoE increases following optic nerve injury in rats, but absolute 
levels do not (19) and apoE mRNA expression by astrocytes in the hippocampus increases after 
entorhinal cortex lesion (36). Neuronal expression of apoE mRNA has been detected in the human 
brain (36). It has been demonstrated that addition of apoE3 stimulates neurite extension in 
transformed murine neuroblastoma (Neuro-2A) cells whereas apoE4 inhibited neurite extension (18). 
Recent studies in apoE KO mice have shown that these mice display significant loss of synapses and 
marked disruption of the dendritic cytoskeleton with age and a reduced recovery following perforant 
pathway lesioning (38- 40). Synaptophysin (a marker for the presynaptic terminals), and 
microtubule-associated protein 2 ( MAP-2, a dendritic marker) in the hippocampus and neocortex of 
apoE KO mice have been shown to decrease when compared to age-matched controls. However, 
other studies have not observed any significant morphological abnormalities in apoE KO mice (41). 
The reasons behind these discrepancies are not clear but differences in the strain and age of control 
and apoE KO mice used may have contributed to the inconsistant results. In contrast to the 
morphological studies, behavioral studies have consistently shown that apoE KO animals exhibit 
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spatial learning deficits (39, 42, 43). Infusion ofrecombinant apoE into the lateral ventricles of apoE 
KO mice reversed behavioral and morphological abnormalities (44). More studies in apoE KO mice 
have also suggested that apoE helps protect the brain against acute injury (45). These data suggest 
that apoE could exert critical effects within the CNS. 
ApoE and Alzheimer's Disease: 
The role of apoE as an important risk factor for AD has been suggested by several studies. The 
characteristic pathology of AD consists of both neuritic plaques and neurofibrillary tangles. The 
neuritic plaques are primarily extracellular and constitute classical amyloid deposits and often a 
neuritic component. The major protein in the plaque is the amyloid beta peptide (Ab), which arises 
by cleavage of the amyloid precursor protein (APP) (46). Studies have shown that apoE is associated 
with Ab deposits in neuritic plaques and in the angiopathy of cerebral vessels ( 4 7). In contrast to 
neuritic plaques, neurofibrillary tangles are intracellular and contain structures referred to as paired 
helical filaments ( 48). ApoE has also been co-localized in these filaments ( 49). The role of plaques 
and tangles in the etiology of AD is unclear. 
There are three forms of AD: early-onset familial, late-onset familial and sporadic disease. 
Early-onset AD represents approximately 5% of patients, where as the late-onset AD accounts for the 
majority of the cases. Recent studies have demonstrated an association between the apoE4 allele and 
late onset familial AD (47). Studies have also shown a significantly higher apoE4 allele frequency in 
the late onset sporadic AD (50). It has been shown that the risk of having early onset AD and disease 
progression increases with an increased dosage of the apoE4 allele (50, 51,). The frequency of the 
apoE4 allele has been shown to be greatly over-represented in late-onset familial AD subjects (52%) 
versus controls (16%), and the risk of AD in individuals homozygous for apoE4 is over five times 
that of homozygous apoE3 individuals (51). A recent report suggests that apoE4 also modulates the 
age of onset of Parkinson's disease. These findings strongly demonstrate a close link between apoE 
polymorphism and the development of neurodegenerative diseases; however, the mechanism behind 
the pathological effects of the apoE remains unknown. 
One possible mechanism of apoE involvement in AD may be on the process involved with neuronal 
plasticity, given that previous studies suggested that apoE may play an important role in peripheral 
nerve regeneration. However, the effects of apoE on the CNS remain unknown. 
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Aim Of The Study: 
The primary objective of this study was to investigate the in vivo effects of apoE on axonal 
growth and synaptogenesis in the CNS. I hypothesized that, lipid redistribution is a critical element 
of neuronal remodeling and that the absence of apoE would disrupt plasticity. To test this hypothesis, 
olfactory nerves of apoE KO mice and wild-type littermate mice were used as a model system. The 
olfactory system was selected because lesioning techniques could be used to amplify the processes 
of tissue repair that normally occur in this system. To determine the time course of changes 
associated with degeneration and regeneration of the olfactory nerve, biochemical studies were used. 
The first aim of this study is to determine the time course of expression of apoE in the olfactory 
bulb of mice following reversible olfactory nerve lesioning. The second aim is to characterize the 
recovery rate of olfactory nerves following nerve lesioning in apoE KO and wild-type mice. 
Recovery was assessed by the expression of marker proteins GAP43 and OMP. GAP 43 is 
specifically expressed in newly formed olfactory neurons (52) and OMP is expressed in mature 
olfactory neurons (53) if they form a functional synapse. 
Basic Structure Of The Olfactory Bulb: 
The anatomy of the olfactory system is relatively simple. The transduction of olfactory 
information occurs in the olfactory epithelium, the sheet of neurons and supporting cells lining the 
nasal turbinates. The epithelium includes several distinct cell types; the most important of these is the 
olfactory receptor neuron (ORN) which is a bipolar neuron. The apical process of this neuron 
contains microvilli, called olfactory cilia which possess membrane receptors. These receptors when 
contacted by substances in inspired air and dissolved in the overlying mucous, transduce odor 
information. This information is carried to the olfactory bulb by the axons of the ORN. These axons 
collect in bundles and form the olfactory nerve which passes through the skull and terminates in the 
olfactory bulb. Besides the ORN, the olfactory epithelium contains two other cell classes, basal and 
sustentacular cells. Basal cells are critical because they divide and form new olfactory neurons (54, 
55). Sustentacular cells help to detoxify chemicals that come in contact with the epithelium. 
The olfactory bulb is a part of the cerebral hemisphere. It is the first CNS relay for olfactory 
input. The bulb is organized in concentric laminae each with characteristic cell types and synaptic 
connectivity. The olfactory nerve layer is the most peripheral layer which is composed of the axons 
of the ORN, sheathing glia and microglia/macrophages. The olfactory receptor axons terminate in the 
glomerular layer, synapsing on the dendrites of mitral cells in large structures called glomeruli. 
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Internal to the glomeruli is the external plexiform layer, which is a cell poor zone containing the 
dendrites of mitral cells and other interneurons. The cell bodies of the mitral cells, the principal 
projection neurons of the olfactory bulb, are located in a distinct mono layer between the external 
plexiform layer and the internal granule cell layer. The granular cell layer, lying below the mitral cell 
layer, is principally composed of small interneurons, called granule cells, whose dendrites ramify in 
the external plexiform layer. The olfactory bulb also contains two other interneurons, tufted cells in 
the external plexiform layer and periglomerular cells surrounding glomeruli. 
Biochemical Denervation Of The Olfactory Bulb: 
Numerous chemicals and physical transection are known to damage the olfactory nerve in mice 
(52- 64). Some chemicals, such as zinc sulphate, can induce degeneration of both the ORN and the 
basal cells and result in either a very prolong regeneration process or complete failure to regenerate. 
Reversible lesioning techniques spare the basal cells and allow regeneration of ORN and replacement 
of the olfactory epithelium. It has been shown that intranasal irrigation of TX in mice causes rapid 
retrograde degeneration of the ORN in the epithelium, with attendant orthograde degeneration of their 
synaptic terminals in the bulb (56, 57), while sparing the basal cells. These basal cells differentiate 
into mature ORN that restablishes functional connections in the bulb. The entire regeneration process 
occurs in approximately 2 months. 
Olfactory System Changes Following Olfactory Nerve Lesion: 
Previous studies have reported a reasonably good timeline for regeneration of the olfactory 
nerve following acute lesions of the receptor mucosa in mice (52, 53, 58- 60). Nerve degeneration 
occuring in the first week following lesioning of the mucosa, is evidenced by loss of olfactory marker 
protein (OMP) and silver stains for degeneration. Three days post lesion, basal cells start to 
proliferate peaking by about five weeks. New axons enter the olfactory nerve layer at one to two 
weeks; and at three weeks, new fibres are visible in the glomeruli. Therefore, within a relatively 
short time, fibres regenerate and reinnervate the olfactory bulb, although the epithelial cell division is 
not complete for five weeks. 
Olfactory nerve lesioning causes visible shrinkage of the olfactory bulb. Wet weight decrease 
by about 30% at two weeks and by 40% at three to four weeks (57, 61, 62). Olfactory nerve-
produced proteins within the bulb, such as OMP and growth associated protein 43 (GAP43) parallel 
olfactory nerve loss, decreasing by 60-80% (52, 53, 63). 
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It has been reported that following a reversible lesion in mice, olfactory nerve recovery starts at 
about two weeks, and consists of two distinct stages (52, 53). The first stage is characterized by the 
formation of a large population of immature olfactory neurons. These newly formed neurons express 
GAP43, a phosphoprotein related to neuronal growth and plasticity. During the second stage the 
newly formed neurons mature when their axons make contact with the olfactory bulb. This stage is 
characterized by a decrease in the expression of GAP43, and an increase in the expression of OMP, a 
protein present only in mature neurons (61). These data suggest that new axons from the epithelium 
enter the bulb at two to three weeks (55, 63). 
The Olfactory System As A Model For Regeneration: 
The adult olfactory system represents an ideal model for studying proteins involved in neuronal 
growth-related processes. First, the primary olfactory receptor neurons regenerate from stem cells 
throughout the life of the organism (65). The exceptional ability of the ORN to regenerate makes it 
an important neural system for studying the mechanisms operative in neuronal degeneration, and 
post-lesion plasticity. Second, the cytoarchitecture and connectivity of the bulb are relatively simple 
which permits reasonably simple interpretations of experimental manipulations. Furthermore, the 
bulb is a closed structure permitting accurate volumetric analyses for use in subsequent studies. 
Third, spatial and temporal separation exists between degeneration and regeneration. Spatially, the 
olfactory nerve is limited to the periphery of the olfactory bulb. Temporally, the olfactory bulb 
response to nerve lesions occurs over several months. 
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MATERIALS & METHODS 
Nasal Irrigation 
The wild type C57BL6J and apE KO mice on the same background used in this study were 
purchased from Jackson Laboratories. Two to three month old mice were lesioned as previously 
described (53, 56, 61). For each time point, an equal number of wild type (n = 8) and apoE KO mice 
(n = 8) were lesioned. Briefly, a 25 gauge needle 10 mm in length with a rounded tip, was inserted 
about 2 mm into one nostril of an unanesthetized mouse, and 100 ul of0.7% (v/v) Triton-XlOO (TX) 
(BP151-500, Fisher, St. Louis, MO) in 0.9% saline or 100 ul of 0.9% saline (control) was squirted 
into the nostril. The excess solution was drained from the nasal passages by gently shaking the 
mouse. This technique results in complete bilateral nerve lesion. Mice were sacrificed at 3,7,21,42 
and 56 days post-treatment . This time course was selected to cover the range of degeneration and 
recovery as previously described (53). 
Sacrifice Procedures 
Following the appropriate survival periods after TX or saline irrigation, mice were anesthetized 
with intraperitonial injection of 100 ul of pentobarbital (80 mg/kg) . A needle was then inserted 
transcardially and animals were thoroughly perfused with phosphate buffered saline (pH 7.4) until the 
perfusate was free of blood. Following perfusion, brains were removed and olfactory bulbs collected 
and homogenized in ice cold 100 ul homo buffer (25 mM Tris HCl pH 7 .6, 3 mM MgC12, 100 mM 
NaCl, 0.28 mM PMSF and 0.25 mM EDTA). Twenty ul of 10% IGEPAL (1-3021 CA-630, Sigma, 
St. Louis, MO) was added to the homogenate and the samples incubated on ice for 30 minutes and 
centrifuged at 14,000 g for 10 minutes to remove the insoluble material. The supernatant was 
collected and stored at -20°C. 
Protein Assay: 
Protein assays were performed by the Lowry method as modified by Peterson (66). Briefly, 5 ul 
of homogenized olfactory bulb sample was diluted to 50 ul with double deionized water. Ten 
microliters of diluted protein samples (in triplicates) were precipitated in order to remove interfering 
substances. One hundred microliters of0.15% Na-deoxycholate (DOC) (BP 349-100, Fisher, St. 
Louis, MO) was added to samples, vortexed and allowed to stand for 10 minutes at room 
temperature. One hundred microlitres of trichloroacetic acid (TCA) (A322-100, Fisher) were added 
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and the samples vortexed and centrifuged at 14,000 g for 25 minutes. The supernatant was discarded 
immediately after centrifugation and the pellet was saved for the assay step. 
The pellet was resuspended in 400 ul of Reagent A (equal volume of dH20, 0.8N NaOH, 
copper tartarate carbonate (CTC) and 10% SDS) vortexed and allowed to stand for 10 minutes at 
room temperature. To samples, 200 ul of Reagent B (1 part Folin-Ciocalteu's phenol reagent (F-
9252, Sigma, St.Louis, MO) and 5 parts dH20) was added, vortexed and incubated for 50 minutes at 
room temperature for color development. Following incubation, absorbance was recorded at 750 nm 
using a spectrophotometer. BSA-Bovine serum albumin (A-7511, fatty acid free, Sigma, St.Louis, 
MO) was used as standard sample for protein assay. 
SDS-Polyacrylamide Gel Electrophoresis: 
Proteins in the olfactory bulb extracts were resolved by SDS-PAGE as previously described 
(18). Briefly, 12% separating gel solution was prepared by mixing 1.67 ml dH20, 1.5 M Tris-HCl 
(pH 8.8), 50 ul of 10% SDS (BP166-100, Fisher) and 2 ml of 30% acrylamide/bis (29.2 gm 
acrylamide (BP200-A, Fisher) and 0.8 gm bisacrylamide (BP200-B, Fisher). To accelerate the rate of 
polymerization, 25 ul of 10% ammonium per sulfate (BP200-C, Fisher) and 5 ul TEMED (N, N, N', 
N'-Tetramethylethylenediamine) (BP200-D, Fisher) was added to mixture and the solution was 
immediately poured into the assembled glass plates and allowed to polymerize for 45 minutes. To 
make the 4% stacking gel, 1.525 ml dH20, 625 ul 0.5M Tris-HCI (pH 6.8), 25 ul of 10% SDS and 
335 ul of 30% acrylamide/bis were mixed gently for 10 minutes. To the mixture, 12.5 ul of 10% 
ammonium per sulfate and 5 ul TEMED were added and it was poured into the gel cassettes. A comb 
was inserted into the stacking gel solution to create wells. The stacking gel was allowed to 
polymerize for 30 minutes at room temperature. 
Eighty micrograms of supernatant was mixed with an equal volume of 2X Lamme Ii sample 
buffer (6.25 ml 4X Tris/SDS pH 6.8, 5 ml glycerol, 1 gm SDS, 0.5 ml 2 mercaptoethanol, 
bromophenol 13.25 ml dH20) and heated at 100°C for 5 minutes. Samples were centrifuged for 5 
minutes at 14,000 g and the supernatant collected. The gel cassettes were inserted into the buffer 
tank of an EC120 Mini gel vertical system (E-C Apparatus Corporation, St. Petersburg, FL) and the 
upper and lower buffer compartments filled with one liter of lX running buffer pH 8.3 [ 250 ml of 
5X running buffer (15 g Tris-base, 72 g glycine( BP381-1, Fisher), 5 g SDS and 750 ml dH20]. The 
samples and 5 ul of kaleidoscope prestained standards (161-0324, Bio-Rad Laboratories, Hercules, 
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CA) were loaded in the wells. The safety cover was replaced in the gel system and the samples were 
run at 80 volts in the stacking gel and at 140 volts in the separating gel. 
Protein Transfer: 
Following gel electrophoresis, the gel cassettes were removed from the buffer tank and the 
plates separated. The stacking gel was removed with a razor blade and the separating gel placed in 
transfer buffer pH 8.3 ( 3.03 gm Tris-base, 14.4 gm glycine, 200 ml methanol and 800 ml dH20) for 
20 minutes on a shaker. The transfer membrane (Immobilon-P IPVHOOOlO, Millipore) was first 
soaked in methanol for 5 seconds and then washed in dH20 for 5 minutes to remove the excess 
methanol. The gel was placed on presoaked filter paper in a gel holder and the transfer membrane 
was placed on top of the gel. The gel holder was placed in the buffer tank of trans-blot transfer cell 
and the entire chamber filled with transfer buffer. Proteins from the gel were transferred onto the 
membrane by passing 100 volts for an hour. The membrane was transferred to blotto (25 gm 
Carnation skim milk powder, 50 ul antifoam A, 5 ul 10% thimerosol, 500 ml borate buffer pH 7.4) 
and incubated overnight on a shaker at 4°C. 
Western Immunoblotting: 
For quantitation of apoE in the samples, the blots were incubated in monoclonal goat anti-
human apoE antibody (1: 1000 dilution in TBS/Tween) (178479, Calbiochem, San Diego, CA) for an 
hour on a shaker, then washed four times (10 minutes each) with wash solution pH 7.4 (8.75 gm 
NaCl, 20 ml 1 M Tris, 1 ml Tween 20 and 2 ml 10% NaN3). Blots were incubated in diluted alkaline 
phosphatase-conjugated donkey anti-goat IgG (1 :2000 dilution in TBS/Tween) (705-055-093, 
Jackson Immuno Research Laboratories Inc, West Grove, PA) for an hour at room temperature on a 
shaker. Blots were then washed with wash solution five times (10 minutes each) and washed twice 
for 10 minutes each with 0.15 M Tris pH 8.8. Blots were processed in developer containing 5 ml 0.15 
M Tris pH 8.8, 33 ul NBT (Nitro BT) (BP108-1, Fisher) and 16.5 ul BCIP (5-Bromo- 4 Chloro-3-
Indolyl Phosphate P-Toluidine salt) (BP1610-100, Fisher) until bands appeared. The primary 
antibody recognized a single band around 35 kDa which is consistent with the published molecular 
weight of apoE (1). 
For quantitation of GAP 43 and OMP, the blots were incubated in monoclonal mouse IgG2 
against GAP 43 antibody (1: 700 dilution in TBS/Tween) (G9264, Sigma, St.Louis, MO) and in goat 
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anti-rat OMP (1 :7000 dilution in TBS/Tween) (67, 68) respectively for an hour. The blots were 
washed with wash solution pH 7.4 four times (10 minutes each). Blots were incubated for GAP 43 in 
secondary alkaline phosphatase-- conjugated goat anti-mouse IgG (1 :2000 dilution in TBS/Tween) 
(115-055-062, Jackson Immuno Research Laboratories Inc, West Grove, PA) for an hour. Blots for 
OMP were incubated in alkaline phosphatase--conjugated donkey anti-goat IgG (1 :2000 dilution in 
TBS/Tween) (705-055-093, Jackson Immuno Research Laboratories, Inc, West Grove, PA) for an 
hour. Blots were washed with wash solution pH 7.4 for five times (10 minutes each) and twice with 
0.15 M Tris pH 8.8 (10 minutes each). Blots were processed in developer until bands appeared. The 
primary antibody recognized a 46 kDa band for GAP 43. A single band around 19 kDa was 
recognized for OMP by the primary antibody (69). All experiments were repeated at least three times 
to assure reproducibility of the results. Bands were quantified by densitometery (Scion Image). As an 
internal control, the blots also contained an olfactory bulb extract from unlesioned animals whose 
level of apoE, GAP 43 or OMP was arbitrarily given a value of one, and all values from different 
time points of the TX- or saline irrigated animals were expressed relative to the unlesioned mouse 
values. 
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RESULTS 
Time Course Of ApoE Expression Following Olfactory Nerve Lesioning In Mice 
In this study, olfactory nerve lesioning was performed by intranasal irrigation of Triton X-100 
(TX) in saline. Following lesioning, olfactory bulbs were collected at 3, 7, 14, 21, 42 and 56 days. 
The time course of apoE expression in the olfactory bulb of wild-type mice was examined using 
immunoblotting techniques. ApoE level peaked at 3 days post-lesioning reaching a concentration 
twice of that found in the normal olfactory bulb. ApoE levels stayed elevated by approximately 1.5 
times the normal level at 7 through 21 days after injury, and thereafter gradually returned to normal 
by 56 days (Fig. 1 & 2) (Table 1). Immunoblots for saline irrigated animals showed no significant 
difference in apoE levels at different time periods (Fig. 1 & 2) (Table 1 ). 
Impact Of ApoE Deficiency On Olfactory Nerve Regeneration In ApoE KO Mice 
Based on the data from this study on apoE expression during nerve regeneration, it was 
hypothesized that if apoE is important in nerve repair, then nerve regrowth should be either 
incomplete or delayed in the absence of apoE. This postulate was tested by comparing olfactory 
nerve repair in apoE KO with control mice. Olfactory nerve recovery was assessed by 
immunoblotting of GAP 43, a marker protein for juvenile olfactory neurons. Immunoblot analysis 
revealed that GAP 43 level in control animals increased by approximately two times the normal level 
at 3 day post-lesion, and returned back to baseline at 7 days after injury. At 21 days post-lesioning 
GAP 43 levels increased dramatically reaching a concentration 3 times which is found in the normal 
olfactory bulb. GAP 43 levels stayed elevated until 42 days, and thereafter gradually returned to 
normal by 56 days (Fig. 4 & 5) (Table 4). 
Even though the GAP 43 time course in apoE KO mice followed a pattern similar to that 
observed in control animals, there were two significant differences. First, the major increase in GAP 
43 was observed on 42 days post- lesioning, which is a two week delay from that observed in control 
animals, suggesting that the generation of new olfactory neurons is delayed by two weeks in apoE 
KO mice. Second, the maximum increase of GAP 43 in apoE KO mice was only two- fold as 
compared to a three- fold rise in control mice. In sum, the data from GAP 43 experiments 
demonstrate that olfactory nerve regeneration is delayed by approximately two weeks in apoE KO 
mice as compared to control animals (Fig. 4 & 5) (Table 7). 
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To confirm the GAP 43 data and examine the effects of apoE deficiency in the maturation of 
olfactory neurons, the expression of olfactory marker protein (OMP) was examined. Immunoblot 
analysis revealed that OMP levels in the bulb of control animals gradually declined following nerve 
lesioning, decreasing to approximately 50% of the normal level at 7 days post- lesioning. Thereafter, 
OMP levels sharply increased to about 80% of the normal level at 21 days post- lesioning, and then 
gradually increased to normal by 56 days (Fig. 6 & 8) (Table 11). These results are consistent with 
previously published results in rats. In apoE KO animals the OMP time course was different than 
that of control animals. First, OMP levels continued to decrease in apoE KO animals until 21 days 
post- lesioning decreasing to approximately 40% of normal OMP levels. Thereafter, OMP levels 
increased slowly reaching only 50% of normal levels on 42 days post- lesioning. OMP levels 
gradually returned to normal on 56 days following injury in apoE KO animals similar to that 
observed in control mice (Fig.7 & 8) (Table 14). Taken together the OMP data demonstrate that 
maturation of olfactory neurons is delayed by two weeks in apoE KO mice as compared to control 
animals, and that it is consistent with the results from our GAP 43 studies. 
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Days Post-Lesion 
0 3 7 21 42 56 
TX 
SL 
Figure 1. Time Course of Apo E expression following olfactory nerve 
lesion. 
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Table 1. Mean comparison of Apo E levels in saline and TX irrigated 
mice following olfactory nerve lesion. 
Saline 
0 Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.00 1.00 0.97 0.88 0.97 0.97 
Exp 2 0.90 1.20 1.30 1.30 0.88 0.88 
Exp 3 1.20 1.10 1.10 1.20 1.10 1.00 
Mean 1.03 1.10 1.12 1.12 0.98 0.95 
Std Dev 0.15 0.10 0.17 0.22 0.11 0.06 
SEM 0.09 0.06 0.09 0.12 0.06 0.04 
Triton 
0 Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.03 2.26 1.66 1.76 1.60 1.40 
Exp 2 0.96 1.70 1.40 1.60 1.20 0.70 
Exp 3 0.70 2.10 1.70 1.40 1.00 1.00 
Mean 0.89 2.02 1.58 1.58 1.26 1.03 
Std Dev 0.17 0.28 0.16 0.18 0.30 0.35 
SEM 0.10 0.16 0.09 0.10 0.17 0.20 
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Table 2. Two way ANOV A for ApoE levels between Saline and TX treated 
control mice. 
Od 3d 7d 21d 42d 
Pooled Variance 0.027 0.046 0.027 0.040 0.053 
Hypothesized 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 
t stat 1.027 -5.219 -3.451 -2.805 -1.510 
P(T<=t) one-tail 0.182 0.003 0.013 0.024 0.103 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.364 0.006 0.026 0.048 0.205 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 
Table 3. Two way ANOV A for ApoE levels between TX treated control 
mice. 
Od&3d 3d & 7d 7d& 21d 21d & 42d 
Pooled Variance 0.057 0.549 0.026 0.063 
Hypothesized 0 0 0 0 
Mean Difference 
df 4 4 4 4 
t stat -5.777 2.266 0 1.562 
P(T<=t) one-tail 0.002 0.043 0.5 0.097 
t Critical one-tail 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.004 0.086 1.000 0.193 
t Critical two-tail 2.776 2.776 2.776 2.776 
56d 
0.063 
0 
4 
-0.404 
0.353 
2.132 
0.706 
2.776 
42d& 56d 
0.108 
0 
4 
0.868 
0.217 
2.132 
0.434 
2.776 
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Figure 2. Comparison of Apo E levels following olfactory nerve lesion. 
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Figure 3. Time course of GAP 43 expression in wild type mice following 
olfactory nerve lesion. 
Days Post-Lesion 
0 3 7 21 42 56 
CO-TX 
CO-SL r1.·• ·· . 
•• • 
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Table 4. Mean comparison of GAP 43 levels in Saline and TX irrigated 
wild type mice. 
Saline 
0 Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.40 1.60 1.30 1.40 1.60 1.40 
Exp 2 1.50 1.00 1.20 1.50 1.40 1.90 
Exp 3 1.50 1.30 1.40 1.80 1.10 1.60 
Mean 1.47 1.30 1.30 1.57 1.37 1.63 
Std Dev 0.06 0.30 0.10 0.21 0.25 0.25 
SEM 0.03 0.17 0.06 0.12 0.15 0.15 
Triton 
O Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.00 2.10 1.40 2.50 2.80 1.30 
Exp 2 1.00 1.60 1.30 2.70 2.70 1.40 
Exp 3 0.90 1.90 1.10 3.40 2.00 0.90 
Mean 0.96 1.87 1.27 2.87 2.50 1.20 
Std Dev 0.07 0.25 0.15 0.47 0.44 0.26 
SEM 0.04 0.15 0.09 0.27 0.25 0.15 
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Table 5. Two way ANOV A for GAP 43 levels between Saline and TX 
treated Wild type mice. 
Od 3d 7d 2ld 42d 
Pooled Variance 0.003 0.076 0.017 0.133 0.136 
Hypothesized 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 
t stat 10.606 -2.506 0.316 -4.360 0.126 
P(T <=t) one-tail 0.000 0.033 0.384 0.006 0.008 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.000 0.066 0.767 0.012 0.017 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 
Table 6. Two way ANOVA for GAP 43 levels between TX treated Wild 
type mice. 
Od& 3d 3d& 7d 7d & 21d 21d & 42d 
Pooled Variance 0.033 0.043 0.123 0.206 
Hypothesized 0 0 0 0 
Mean Difference 
df 4 4 4 4 
t stat -6.037 3.530 -5.580 0.988 
P(T <=t) one-tail 0.002 0.012 0.002 0.189 
t Critical one-tail 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.003 0.024 0.005 0.379 
t Critical two-tail 2.776 2.776 2.776 2.776 
56d 
1.633 
0 
4 
2.055 
0.054 
2.132 
0.109 
2.776 
42d & 56d 
0.130 
0 
4 
4.416 
0.005 
2.132 
0.011 
2.776 
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Figure 4. Time course of GAP 43 expression in Apo E KO mice following 
Olfactory nerve lesion. 
KO-TX 
KO-SL 
Days Post-Lesion 
0 3 7 21 42 56 
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Table 7. Mean comparison of GAP 43 levels in saline and TX irrigated 
Apo E KO mice. 
Saline 
O Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.00 1.50 1.30 1.20 1.30 0.90 
Exp 2 1.00 1.30 1.10 0.90 0.90 1.30 
Exp 3 0.90 1.60 1.50 1.50 1.10 1.00 
Mean 0.96 1.47 1.30 1.20 1.10 1.07 
Std Dev 0.07 0.15 0.20 0.30 0.20 0.21 
SEM 0.04 0.09 0.12 0.17 0.12 0.12 
Triton 
0 Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.10 1.60 1.60 1.70 2.30 1.10 
Exp 2 0.90 1.70 1.20 1.50 2.00 1.10 
Exp 3 1.10 1.90 1.00 1.50 1.80 1.00 
Mean 1.03 1.73 1.27 1.57 2.03 1.07 
Std Dev 0.12 0.15 0.31 0.12 0.25 0.06 
SEM 0.07 0.09 0.18 0.07 0.15 0.03 
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Table 8. Two way ANOV A for GAP 43 levels between Saline and TX 
treated apoE KO mice. 
Od 3d 7d 21d 42d 
Pooled Variance 0.008 0.023 0.066 0.051 0.051 
Hypothesized 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 
t stat -0.894 -2.138 0.158 -1.976 -5.029 
P(T <=t) one-tail 0.210 0.049 0.441 0.060 0.003 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.421 0.099 0.882 0.119 0.007 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 
56d 
0.023 
0 
4 
0.000 
0.500 
2.132 
1.000 
2.776 
Table 9. Two way ANOV A for GAP 43 levels between TX treated apoE KO 
mice. 
Od&3d 3d& 7d 7d & 21 d 21d& 42d 42d & 56d 
Pooled Variance 0.018 0.058 0.053 0.038 0.033 
Hypothesized 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 
t stat -6.331 2.366 -1.591 -2.919 6.484 
P(T <=t) one-tail 0.001 0.038 0.093 0.021 0.001 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.003 0.077 0.187 0.043 0.003 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 
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Figure 5. Comparison of GAP 43 levels between wild type and Apo E KO 
mice following olfactory nerve lesion. 
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Table 10. Two way ANOV A for GAP 43 levels between TX treated Wild 
type and apoE KO mice. 
Od 3d 7d 21d 42d 
Pooled Variance 0.008 0.043 0.025 0.118 0.126 
Hypothesized 0 0 0 0 0 
Mean Difference 
df 4 4 4 4 4 
t stat -0.894 0.784 0.000 4.628 1.606 
P(T <=t) one-tail 0.211 0.238 0.500 0.005 0.091 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.421 0.476 1.000 .001 0.183 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 
56d 
0.036 
0 
4 
0.852 
0.221 
2.132 
0.441 
2.776 
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Figure 6. Time course of OMP expression in wild type mice following 
olfactory nerve lesion. 
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Table 11. Mean comparison of OMP levels in saline and TX irrigated wild 
type mice. 
Saline 
0 Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.00 1.00 0.90 1.00 1.00 1.10 
Exp 2 0.90 1.10 1.20 1.10 1.20 0.80 
Exp 3 1.10 1.10 1.00 1.20 1.10 1.00 
Mean 1.00 1.07 1.03 1.10 1.10 0.97 
Std Dev 0.10 0.06 0.15 0.10 0.10 0.15 
SEM 0.06 0.03 0.09 0.06 0.06 0.09 
Triton 
0 Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.00 0.80 0.70 0.80 0.80 0.90 
Exp 2 1.00 0.80 0.50 0.90 0.90 1.00 
Exp 3 0.70 0.70 0.40 0.60 0.80 0.90 
Mean 0.90 0.77 0.52 0.77 0.83 0.93 
Std Dev 0.17 0.06 0.13 0.15 0.06 0.06 
SEM 0.10 0.03 0.08 0.09 0.03 0.03 
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Table 12. Two way ANOV A for OMP levels between Saline and TX treated 
Wild type mice. 
Od 3d 7d 21d 42d 56d 
Pooled Variance 0.020 0.003 0.023 0.017 0.007 0.013 
Hypothesized 0 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 4 
t stat 0.866 6.364 4.009 3.162 4 0.353 
P(T <=t) one-tail 0.217 0.001 0.008 0.017 0.008 0.370 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.435 0.003 0.016 0.034 0.016 0.741 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 2.776 
Table 13. Two way ANOVA for OMP levels between TX treated Wild type 
mice. 
Od&3d 3d&7d 7d & 21d 21d &42d 42d& 56d 
Pooled Variance 0.016 0.013 0.023 0.013 0.003 
Hypothesized 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 
t stat 1.265 2.475 -1.870 -0.707 -2.121 
P(T <=t) one-tail 0.137 0.0342 0.067 0.259 0.050 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.274 0.068 0.134 0.518 0.101 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 
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Figure 7. Time course of OMP Expression in Apo E KO mice following 
olfactory nerve lesion. 
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Table 14. Mean comparison of OMP levels in saline and TX irrigated 
Apo E KO mice. 
Saline 
O Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.00 1.00 0.90 1.10 1.00 0.70 
Exp 2 0.80 1.10 1.00 0.90 0.90 0.90 
Exp 3 1.10 1.00 1.10 1.10 1.10 1.10 
Mean 0.97 1.03 1.00 1.03 1.00 0.90 
Std Dev 0.15 0.06 0.10 0.12 0.10 0.20 
SEM 0.09 0.03 0.06 0.07 0.06 0.12 
Triton 
0 Days 3 Days 7 Days 21 Days 42 Days 56 Days 
Exp 1 1.00 0.80 0.70 0.50 0.60 0.70 
Exp 2 1.00 0.80 0.50 0.40 0.40 0.90 
Exp 3 0.90 1.00 0.40 0.30 0.70 0.90 
Mean 0.95 0.87 0.53 0.40 0.57 0.83 
Std Dev 0.05 0.12 0.15 0.10 0.15 0.12 
SEM 0.03 0.07 0.09 0.06 0.09 0.07 
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Table 15. Two way ANOVA for OMP levels between Saline and TX treated 
apoE KO mice. 
Od 3d 7d 21d 42d 56d 
Pooled Variance 0.013 0.008 0.016 O.Ql 1 0.016 0.026 
Hypothesized 0 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 4 
t stat 1.185 2.236 4.427 7.181 4.110 0.500 
P(T <=t) one-tail 0.500 0.044 0.006 0.001 0.007 0.321 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 1.000 0.089 O.Qll 0.002 0.015 0.643 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 2.776 
Table 16. Two way ANOV A for OMP levels between TX treated apoE KO 
mice. 
Od&3d 3d&7d 7d & 21d 21d& 42d 42d& 56d 
Pooled Variance 0.008 O.Q18 0.016 0.016 0.018 
Hypothesized 0 0 0 0 0 
Mean Difference 
Df 4 4 4 4 4 
t stat 1.341 3.015 1.264 -1.581 -2.412 
P(T <=t) one-tail 0.125 0.019 0.137 0.094 0.036 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.251 0.039 0.274 0.189 0.073 
T Critical two-tail 2.776 2.776 2.776 2.776 2.776 
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Figure 8. Comparison ofOMP levels between wild type and Apo E KO 
mice following olfactory nerve lesion. 
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Table 17. Two way ANOV A for OMP levels between TX treated Wild type 
and apoE KO mice. 
Od 3d 7d 21d 42d 
Pooled Variance 0.016 0.008 0.023 0.016 0.013 0.008 
Hypothesized 0 0 0 0 0 0 
Mean Difference 
df 4 4 4 4 4 4 
t stat -0.632 -1.341 0.000 3.478 2.828 1.341 
P(T <=t) one-tail 0.280 0.125 0.500 0.012 0.023 0.125 
t Critical one-tail 2.132 2.132 2.132 2.132 2.132 2.132 
P(T <=t) two-tail 0.561 0.250 1.000 0.025 0.047 0.250 
t Critical two-tail 2.776 2.776 2.776 2.776 2.776 2.776 
34 
56d 
DISCUSSION 
Apolipoprotein E is unique among apolipoproteins in that it has a special relevance to the 
nervous system. The role of apoE in neurobiology has been suggested by a series of observations 
made over the past several years. First, apoE messenger RNA is abundant in the brain and is 
synthesized and secreted primarily by astrocytes. Second, apoE-containing lipoproteins are found in 
the cerebrospinal fluid and appear to play a major role in lipid transport in the CNS. Third, apoE, 
together with a source cholesterol, promotes marked neurite extension in cultured dorsal root 
ganglion cells. Fourth, apoE levels increase dramatically after peripheral nerve injury. Recently, 
apoE4 has been implicated in the pathogenesis of AD, but the mechanism by which apoE is linked to 
the disease is unknown. The aim of this study was to understand the role of apoE in the CNS during 
nerve regeneration. 
To test my hypothesis, I used olfactory nerves of mice as the model system. The ability to cause 
central degradation by peripheral manipulation makes the primary olfactory pathway a very attractive 
neural system to study. This model system has many distinct advantages. First, this pathway is quite 
suited to regeneration studies since the perikarya lie outside the central nervous system and are fairly 
accessible in the nasal epithelium while the synaptic endings are within the cranium itself, in the 
olfactory bulb. Second, the olfactory bulb has a simple organization with discrete input and output 
neurons and it is the only region in the CNS in which total degeneration of the primary sensory 
nerves can be experimentally induced after which reinnervation results in reconstitution of the system 
(63, 70, 71, 72, 73). Third, the olfactory receptor cells have a unique property among the neurons of 
the central nervous system in that they are capable of regenerating and reinnervating the olfactory 
bulb following chemical or mechanical lesion of their axons (63, 71, 74). Fourth, the olfactory 
epithelium contains a population of immature, precursor cells which are capable of differentiating 
into functional neurons following the death of mature neurons (75, 76), and this process continues 
even in the absence of any exogenous insult. Experimental manipulation of the olfactory nerve by 
chemical lesioning is a useful technique in determining the functions of apoE in a well-defined neural 
system. For this purpose, I used olfactory nerves of apoE KO mice that are specifically and 
completely deficient in the expression of apoE. These mice provide a useful system to test directly 
whether apoE is an essential component of nerve regeneration. Intranasal irrigation with zinc sulfate 
or vinblastine sulfate causes severe damage to the olfactory epithelium, and prevents any neural 
regeneration from occurring (62, 63, 77). I used 0.7% Triton X-100 for intranasal irrigation to 
perform olfactory nerve lesioning in mice. It has been shown that intranasal irrigation with Triton X-
100 (0.5%) destroyed mature olfactory receptor neurons, but allowed regeneration to occur. 
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Morphological studies have shown an extensive loss of the olfactory epithelium from the turbinates, 
the accumulation of epithelial debris in the airways and absence of a ciliary layer from the mucosa 
following TX lesion in mice (78). TX treatment has been shown to severely damage the olfactory 
epithelium both in wild-type and in apoE KO mice. After one week post-lesioning, the mean 
damaged olfactory mucosa has been shown to be similar in wild-type and apoE KO mice (89% of 
total olfactory mucosa in wild-type and 90% in apoE KO mice). 
Previous studies have indicated a possible role for apoE in the plasticity of the CNS (79, 80, 
81 ), suggesting that apoE might be critical in maintaining the integrity of the CNS during aging and 
after lesions (27, 82). This study substantiates previous investigations which have indicated a role for 
apoE in the CNS response to injury (27, 36, 83). In initial experiments, I examined the temporal 
expression of apoE levels following olfactory nerve injury. The results indicate that there is a 
significant increase in apoE levels at 3 day post-lesioning which gradually declines to normal levels 
by 56 day. In the central nervous system, apoE is primarily synthesized and secreted by astrocytes 
and macrophages (9, 81, 84). In normal nerve tissue, small amounts of apoE are produced primarily 
by resident macrophages and LDL receptors are expressed on many nerve cells, indicating that apoE 
is involved in cholesterol transport within the nervous system at all times and its synthesis is 
increased after injury. It may be that injury and repair only modulate the activity of this system. 
Cholesterol liberated from degenerating axons serves as a local source for the subsequent 
reactive synaptogenesis that takes place in this system (85). Studies on cholesterol fed macrophages 
have shown that free cholesterol increases mRNA levels and results in increased apoE biosynthesis 
and secretion (86). During first week post-lesion, astrocytes engulf the degenerated synaptic 
terminals and preterminal axons which generate a large store of cholesterol and lipids readily 
available for the synthesis of membrane components for new synapses, and may act as a trigger to 
induce the up-regulation of apoE. As a result of increased apoE expression and in the presence of 
active synaptogenesis and terminal proliferation, there is a decrease in intracellular cholesterol 
synthesis (27). 
Alterations in the cellular localization of apoE can occur following brain injury. There is 
evidence that apoE is increased in astrocytes following transient cerebral ischemic injury and acute 
subdural hematoma in rat and are taken up into neurons which are destined to die (35, 87). Following 
injury, apoE transports cholesterol and lipids to cells for synaptic remodeling and repair. An increase 
in apoE immunoreactivity in neurons following the initial ischemic insult indicates a rapid protective 
response by supplying cholesterol to neurons for repair (88). Receptors for apoE are located in 
neuronal cell bodies and dendrites (89), suggesting that apoE could be incorporated into neurons 
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through this mechanism. Furthermore, apoE can be internalized by neurons (20) and may serve as a 
major cholesterol carrier to the neurons (80). As axons regenerate, their advancing tips express high 
levels of LDL receptors which have been postulated to participate in uptake of apoE containing 
lipoproteins (90). Cholesterol rich apoE containing lipoproteins bind with high affinity to these LDL 
receptors (1, 91, 92). The presence of apoE and expression of LDL receptors at the elongating tips of 
axons provide a mechanism for cholesterol transfer among macrophages and regenerating axons. It 
has been shown that nonesterified cholesterol is released, esterified, and transported by apoE to 
neurons undergoing regeneration where it is taken up through the LDL receptor pathway and it is 
used as a precursor for the synthesis of new synaptic terminals (27). The presence of this cholesterol 
transport system to the damaged neurons involving apoE, coupled with conservation of cholesterol 
within the degenerating nerve, suggests that cholesterol is important for regeneration to keep up with 
the massive membrane biogenesis that occurs in the regenerating nerve. 
The relative rate of apoE biosynthesis and secretion has been shown to decrease to normal 
values in crushed peripheral nerves 56 days after injury (93). A decline in apoE secretion and 
accumulation of apoE containing lipoprotein particles within the regenerating nerve are concurrent 
with the depletion and the unloading of cholesterol stores from macrophages. As axonal growth 
proceeds, the apoE levels reduce and reach normal levels once axons make their contact with their 
target sites in the CNS. ApoE has also been shown to be present around the glomeruli and the 
olfactory nerve in both mouse and human (78). These studies and our results suggest that apoE is 
involved in cholesterol transport and associated with the continuous degeneration and regeneration 
processes that occur in the CNS. 
The significance of apoE uptake into neurons and increase in extracellular apoE may have 
important implications regarding human pathology particularly in relation to Alzheimer's disease. It 
has been demonstrated that intraneuronal apoE occurs in response to injury (87). A similar 
mechanism may occur in Alzheimer brain such that following a compromise in cellular homeostasis 
apoE is released and taken up into neurons. The apoE present in neurons may interact with 
microtubule associated proteins such as tau, and depending on the apoE isoform, ultimately lead to 
neurofibrillary tangle formation. 
ApoE knockout mice offer a unique opportunity to study, in vivo, the role of apoE in 
the CNS. ApoE KO mice have been shown to have decreased resistance to focal cerebral 
ischemia when compared with wild-type animals (94). Following middle cerebral artery 
occlusion, apoE KO mice had large infarcts and high mortality rates as compared to controls (94). 
Reinnervation of the molecular layer of dentate gyrus after interruption of the perforant pathway is 
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abnormal (82). Severe motor and behavioral deficits after close head injury and reduced brain 
cholinergic activities and impaired cognition have also been reported (41, 45). ApoE KO mice 
display an age-dependent disruption of the synaptic and dendritic organization of the neocortex and 
hippocampus when compared to controls (38). Infusion of apoE into the lateral ventricles 
of apoE KO mice has been shown to correct the synapto-dendritic pathology, indicating that 
these alterations are reversible (40). These observations suggest that apoE plays a possible role 
in synaptic remodeling and maintaining the integrity of the CNS during aging and after injury (27, 
36). 
To further investigate the importance of apoE in the CNS, I used olfactory nerves of apoE KO 
mice compared to wild-type mice to determine the rate of axonal growth, synaptogenesis and 
olfactory neuron maturation in the absence of apoE. For this purpose, GAP 43 and OMP were used 
as marker proteins. It was found that olfactory nerve regeneration occurred in apoE KO mice, but the 
rate of axonal growth and maturation of olfactory neurons is delayed in these mice by two weeks 
compared to controls. These results are consistent with previous reports that nerve regeneration in 
the peripheral nervous system in apoE KO mice is normal, and that apoE is not essential for nerve 
repair (95). It has been reported that HMG-CoA reductase, a rate limiting enzyme in cholesterol 
synthesis, decreased mRNA and activity levels to the same degree in the crushed nerves of wild-type 
and apoE KO mice (95, 96). These studies suggest that regenerating nerves of apoE KO mice do not 
synthesize large quantities of cholesterol, and therefore the cholesterol present in the nerve before 
injury is conserved and reutilized in the regenerating nerves of these animals. This apparent 
recycling of lipids in apoE KO mice suggest that other apolipoproteins in the regenerating nerve may 
be capable of functionally substituting for apoE. There is a ~500 fold increase in the concentration of 
apolipoprotein D, as well as 15-25 fold increase in concentrations of apolipoprotein A-I and 
apolipoprotein A-IV in the crushed nerves of wild-type animals (79). Apolipoprotein Dis expressed 
by fibroblast-like cells and glial cells in the CNS (97), and a rapid and sustained local increase in 
apoD mRNA and apoD immunoreactive protein has been observed following entorhinal cortex lesion 
in the rat hippocampus (98). It appears that any of the substituting apolipoproteins can fill the role of 
apoE as an acceptor for cholesterol and ligand for the LDL receptor, and in the normal transfer of 
cholesterol to the regenerating nerve, thus ensuring lipid transfer within CNS for the maintenance of 
normal function. 
The rate of nerve regeneration depends in part upon the efficiency of lipid transport from the 
local environment to the elongating axon. The presence of axonal degeneration products in wild-type 
animals peaks within the first week following the lesion, and products are then cleared from the 
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denervated zone by glial cells by the second week (99, 100). ApoE expression has been shown to 
increase in astrocytes within the first post-lesion week supporting a role for apoE in these events (36). 
Persistence of degenerating products in the hippocampus of apoE KO mice has been reported in the 
injured brain. Therefore, it has been suggested that apoE is involved in the clearance of neuronal 
degeneration products in the injured brain, perhaps via its ability to transport cholesterol and other 
lipids released from damaged neuronal membranes. The delay observed in axonal extension and 
olfactory neuron maturation in apoE KO mice in this study could be explained due to inefficient 
clearance of cholesterol-laden neurodegeneration products, and a delay in their transport to new 
membrane components and growing axons. 
The aim of this study is to understand the role of apoE in the CNS during nerve regeneration. 
The results show that apoE expression is upregulated following olfactory nerve injury and stay 
elevated for a long time, which suggests it is involved not only in degeneration process but also 
during nerve regeneration. Consistent with the hypothesis that lack of apoE would disrupt the CNS 
plasticity, our results show that nerve regeneration is delayed in apoE KO mice following olfactory 
nerve injury. It suggests that may be in the absence of apoE, some other protein is taking over 
apoE's function, but it is not as efficient as apoE in lipid transport. Similar to what has been shown 
in mice, if apoE3, the most common isoform of apoE is present in humans, may help facilitate nerve 
repair in the aging brain. However, if apoE4, the mutant form is present, then it may not fulfil apoE's 
function in nerve repair processes, and therefore will lead to AD. Thus, it is concluded that apoE 
plays a pivotal role in nerve repair following injury, and apoE deficiency in leads to delayed nerve 
repair. 
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